Daisuke Minakata, Go Yamamoto, Shinichi Kako, Yuki Hiroshima, Shuichi Ota, Tomoyuki Handa et al. Response-adapted lenalidomide–dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study. // Blood Research. – 2026. – DOI: 10.1007/s44313-026-00154-1. – URL: https://doi.org/10.1007/s44313-026-00154-1
Daisuke Minakata, Go Yamamoto, Shinichi Kako, Yuki Hiroshima, Shuichi Ota, Tomoyuki Handa, Atsushi Wake, Akiko Meguro, Kensuke Usuki, Nobuhiro Tsukada, Hideki Nakasone, & Yoshinobu Kanda (2026). Response-adapted lenalidomide–dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study. Blood Research. https://doi.org/10.1007/s44313-026-00154-1
Daisuke Minakata, et al. “Response-adapted lenalidomide–dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study.” Blood Research, 2026. doi:10.1007/s44313-026-00154-1.
@article{Minakata2026,
title = {Response-adapted lenalidomide–dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study},
author = {Minakata, Daisuke and Yamamoto, Go and Kako, Shinichi and Hiroshima, Yuki and Ota, Shuichi and Handa, Tomoyuki and Wake, Atsushi and Meguro, Akiko and Usuki, Kensuke and Tsukada, Nobuhiro and Nakasone, Hideki and Kanda, Yoshinobu},
journal = {Blood Research},
year = {2026},
doi = {10.1007/s44313-026-00154-1},
url = {https://doi.org/10.1007/s44313-026-00154-1}
}